Taysha Gene Therapies Stock Performance
as on October 24, 2026 at 6:28 am IST
Day's Low
Day's High
$3.75$3.92
2.60%
Downside
1.82%
Upside
52 Week's Low
52 Week's High
$3.46$7.3010.26%
Downside
89.61%
Upside
Taysha Gene Therapies share price movements today
- Previous Close
- $4.00
- Open
- $3.86
- Volume
- 1.0M
- Market Cap
- $1.3B
- Day's Low - High
- $3.75 - $3.92
- 52 Week Low - High
- $3.46 - $7.30
Taysha Gene Therapies Historical Returns
- 1 Month Return
- -18.43 %
- 3 Month Return
- -31.3 %
- 1 Year Return
- -18.93 %
- 3 Year Return
- + 83.72 %
- 5 Year Return
- -74.57 %
Taysha Gene Therapies Stock Fundamentals & Key Indicators
Check Taysha Gene Therapies market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.3B
EPS (TTM)
-0.4226
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-9.75
Industry PE ratio
-7.12
PEG Ratio
0.59
EBITDA
-148.9M
Revenue (TTM)
5.5M
Profit Margin
83.96%
Return On Equity TTM
-56.19%
Taysha Gene Therapies vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Taysha Gene Therapies with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $1.3B | -74.57% | -9.75 | 83.96% | 0.00% | |
| Neutral | $98.1B | -37.95% | -30.80 | -12.57% | 0.00% | |
| StrongBuy | $44.0B | NA | 27.47 | 87.82% | 0.00% | |
| StrongBuy | $132.9B | 191.61% | 30.28 | 86.04% | 0.00% | |
| Buy | $83.1B | 43.11% | 19.24 | 84.86% | 0.46% |
Stock Returns calculator for Taysha Gene Therapies Stock including INR - Dollar returns
The Taysha Gene Therapies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Taysha Gene Therapies investment value today
Current value as on today
₹84,293
Returns
Returns from Taysha Gene Therapies Stock
Dollar Impact
₹6,358 (+6.36%)
Analyst Recommendation on Taysha Gene Therapies Stock
Based on 5 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Taysha Gene Therapies. Average target price of $13
Taysha Gene Therapies Share Price Target
Get share price movements and forecasts by analysts on Taysha Gene Therapies.
What analysts predicted
70.38%UPSIDE
Target Price
$13
Current Price
$3.85
Analyzed by
5 Analysts
High
$19
Target
$13.00
Low
$12
Taysha Gene Therapies target price $13, a slight upside of 70.38% compared to current price of $3.85. According to 5 analysts rating.
Indian Investors' Interest in Taysha Gene Therapies Stock
Search interest for Taysha Gene Therapies Stock has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Taysha Gene Therapies Quarterly Profit & Loss
All numbers in Millions USD
Taysha Gene Therapies Annual Profit & Loss
All numbers in Millions USD
Taysha Gene Therapies Quarterly Cash Flow
All numbers in Millions USD
Taysha Gene Therapies Annual Cash Flow
All numbers in Millions USD
Insights on Taysha Gene Therapies
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 7 days, TSHA stock has moved up by 10.6%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 690.8%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 157.7% return, outperforming this stock by 74.0%
About Taysha Gene Therapies
| Organisation | Taysha Gene Therapies |
| Headquarters | 3000 Pegasus Park Drive, Dallas, TX, 75247, US |
| Industry | Biotechnology |
| CEO | Sean Nolan |
Key Management of Taysha Gene Therapies
Name | Title |
|---|---|
Dr. Sukumar Nagendran M.D. | President, Head of Research & Development and Director |
Ms. Emily McGinnis M.P.H. | Chief Patient & External Affairs Officer |
Mr. Sean McAuliffe | Chief Business Officer |
Dr. Steven Gray Ph.D. | Chief Scientific Advisor of UT Southwestern Gene Therapy Program |
Berge Minassian M.D. | Chief Medical Advisor of UT Southwestern Gene Therapy Program |
Mr. Sean P. Nolan | CEO & Chairman |
Mr. Kamran Alam CPA, M.B.A. | CFO & Corporate Secretary |
Hayleigh Collins | Director of Corporate Communications & Investor Relations |
Mr. Michael B. Johannesen | Chief Legal Officer & Corporate Secretary |
Mr. Frederick Porter Ph.D. | Chief of Staff & Technical Operations Officer |
FAQs
What is Taysha Gene Therapies share price today?
Taysha Gene Therapies share price today is $3.85 as on . Taysha Gene Therapies share today touched a day high of $3.92 and a low of $3.75.
What is the 52 week high and 52 week low for Taysha Gene Therapies share?
Taysha Gene Therapies share touched a 52 week high of $7.30 on and a 52 week low of $3.46 on . Taysha Gene Therapies stock price today i.e. is trending at $3.85,which is 47.26% down from its 52 week high and 11.43% up from its 52 week low.
What is Taysha Gene Therapies's market capitalisation today?
Taysha Gene Therapies market capitalisation is $0.00T as on .
How to invest in Taysha Gene Therapies Stock (TSHA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Taysha Gene Therapies on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Taysha Gene Therapies Stock (TSHA) from India?
Indian investors can start investing in Taysha Gene Therapies (TSHA) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in Taysha Gene Therapies stock (as per the Rupee-Dollar exchange rate as on ).
Based on Taysha Gene Therapies share’s latest price of $3.85 as on October 24, 2026 at 12:58 am IST, you will get 2.5974 shares of Taysha Gene Therapies. Learn more about
fractional shares .
What are the returns that Taysha Gene Therapies has given to Indian investors in the last 5 years?
Taysha Gene Therapies stock has given -74.57% share price returns and 26.35% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?